Since the publication of our article in CMAJ, 1 there have been substantial developments in the literature regarding the role of renin–angiotensin–aldosterone system (RAAS) inhibitors in patients with ...

KEY POINTS Chronic hyperkalemia is prevalent among patients with chronic kidney disease, heart failure or other conditions treated with renin–angiotensin–aldosterone system (RAAS) inhibitors, and has ...